Sveriges mest populära poddar

Bloomberg Intelligence

Bloomberg Intelligence

Merrimack's Mulroy on Success of Pancreatic Drug Onivyde(Audio)

11 min•10 maj 2016

Om avsnittet

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Bob Mulroy, CEO of Merrimack Pharmaceuticals, on biotech earnings, consumer health and oncology, and its product pipeline. Broadcasting live from the Boston Convention and Exhibition Center.

See omnystudio.com/listener for privacy information.

Fler avsnitt

Apple Is Ready to Make Long-Awaited Push Into Smart-Home Market

Smart Ring Maker Oura Delays IPO

Nvidia Boosts Share Buyback Program by $150 Billion

What The Bond Selloff Means For Your Wallet & Simplifying Finance For Your Family

Muse Powers Meta to Cusp of $2 Trillion in Best Month Since 2013

Meta Introduces Palm-Sized Device to Use Muse AI

Disney+ Price to Jump 13% to $21.49 Per Month

Meta’s New Muse AI App Makes Shopping Easier

Paramount to Settle Lawsuits Against WBD Deal

The Bank of Mom & Dad; College Sports Going Pro & The Return of the Suit

Bloomberg Intelligence med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.